Carent Medico Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.23 M
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.13 Cr
- Revenue Growth %
- Net Worth -99.04%
- Total Assets -97.48%
About Carent Medico
Carent Medico Private Limited (CMPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 13 August 2020 (Four years and five months 17 days old ). Its registered office is in Jhansi, Uttar Pradesh, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.23 M.
The company currently has active open charges totaling ₹3.13 Cr.
Kuldeep Jha, Sandharbh Solanki, Prince Singh, and Two other members serve as directors at the Company.
Company Details
- Location
Jhansi, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U85100UP2020PTC132641
- Company No.
132641
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Aug 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Carent Medico?
Board Members (5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kuldeep Jha | Director | 13-Aug-2020 | Current |
Sandharbh Solanki | Director | 13-Aug-2020 | Current |
Prince Singh | Director | 18-May-2023 | Current |
Ajay Rathore | Director | 18-May-2023 | Current |
Udit Trivedi | Director | 18-May-2023 | Current |
Financial Performance of Carent Medico.
Carent Medico Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 99.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss | |||||||
Net Worth |
| ||||||
EBITDA |
What is the Ownership and Shareholding Structure of Carent Medico?
In 2021, Carent Medico had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹31.30 M
₹0
Charges Breakdown by Lending Institutions
- Others : 3.13 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
21 Dec 2022 | Others | ₹3.13 Cr | Open |
How Many Employees Work at Carent Medico?
Carent Medico has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Carent Medico, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Carent Medico's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.